U.S. Congress

Opioid law draws scrutiny after Trump's pick for drug czar steps aside


President Trump's pick to be the nation's drug czar, Rep. Tom Marino (R-Pa.), withdrew from consideration Tuesday after news reports focused attention on his role in pushing legislation that weakened the Drug Enforcement Administration's power to investigate bulk shipments of prescription opiods.

Adding to the backlash, some members of Congress now say they will try to reverse Marino's bill, and the Department of Justice plans to assess whether the 2016 law restricts investigations.

“We’re going to review it,"...

EDITION: California | U.S. & World